Bexarotene--an alternative therapy for progressive cutaneous T-cell lymphoma? First experiences. [electronic resource]
Producer: 20051205Description: 785-9 p. digitalISSN:- 1610-0379
- Adult
- Aged
- Aminoquinolines -- therapeutic use
- Anticarcinogenic Agents -- administration & dosage
- Antineoplastic Agents
- Antineoplastic Combined Chemotherapy Protocols
- Bexarotene
- Combined Modality Therapy
- Cyclophosphamide
- Disease Progression
- Doxorubicin
- Female
- Humans
- Imiquimod
- Immunosuppressive Agents -- therapeutic use
- Interferons -- therapeutic use
- Lymphoma, T-Cell, Cutaneous -- drug therapy
- Male
- Middle Aged
- Neoplasm Staging
- PUVA Therapy
- Pilot Projects
- Prednisone
- Remission Induction
- Skin -- pathology
- Skin Neoplasms -- drug therapy
- Tacrolimus -- therapeutic use
- Tetrahydronaphthalenes -- administration & dosage
- Time Factors
- Treatment Outcome
- Vincristine
No physical items for this record
Publication Type: Comparative Study; Evaluation Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.